Cornea Reports

Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic industry.

2022 Ophthalmic Landscape Report: Global Analysis for 2021 to 2027, December, 2023

The third-edition “2022 Ophthalmic Landscape Report” offers a high-level analysis of the 2022 global ophthalmic market by region and subspecialty and forecasts market performance over the next five years. It discusses important trends and key factors for future success.

2023 Cornea Products Market Report: Global Analysis for 2022 to 2028, December, 2023

The “2023 Cornea Products Market Report” provides an overview of corneal diseases and gives estimates for the populations in six disease categories. The report discusses cornea products and treatments and revenue forecasts for cornea transplants, therapeutic lenses, PTK, intrastromal corneal ring segments, and corneal crosslinking. It also reviews organ donation policy, regulations, and the role of cornea specialists, eye banks, and other organizations.

This report considers over 70 products from more than 50 companies in its market forecasts and discusses the upcoming pipeline of new technologies that have yet to recognize revenue. Hundreds of eye banks, research institutes, and NGOs are also considered. Also included are 12 in-depth company profiles on key market players.

2023 Corneal Disease Model, December, 2023

Market Scope’s "2023 Corneal Disease Model" offers extensive country-level prevalence data and five-year forecasts for nine corneal diseases for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Want to Purchase the Full Report?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more